Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Migration of neutrophils (PMN) across epithelia is a pathological hallmark of numerous muco‐sal diseases. Whereas lesions at mucosal surfaces are generally self‐limiting, endogenous mechanisms of resolution are incompletely understood. Previous studies revealed that resolvins directly act on PMN to attenuate transendothelial migration, less is known about the influence of resolvins on PMN‐epithelial interactions and whether they act on epithelia. We studied the dynamics of resolvin E1 (RvE1) actions on leukocyte transepithelial migration. PMN exposure to RvE1 or chemerin (peptide agonist of ChemR23) reduced trans‐epithelial migration in a concentration‐dependent manner. Conversely, activation of epithelial ChemR23 promoted apical clearance of PMN. A nonbiased screen of known PMN ligands expressed on epithelial cells in response to RvE1 revealed selective induction of CD55, an apically expressed antiadhesive molecule. CD55 promoter analysis demonstrated that both RvE1 and chemerin activate the CD55 promoter. Inhibition of CD55 by neutralizing antibody prevented RvE1‐depen‐dent augmentation of apical PMN clearance. Taken together these findings implicate a “two‐hit” model of inflammatory resolution, whereby activation of the PMN RvE1 receptor attenuates transepithelial migration and subsequent actions on the epithelium promote CD55‐dependent clearance of PMN across the epithelial cell surface promoting active inflammatory resolution.—Campbell, E. L., Louis, N. A., Tomassetti, S. E., Canny, G. O., Arita, M., Serhan, C. N., Colgan, S. P. Resolvin E1 promotes mucosal surface clearance of neutrophils: a new paradigm for inflammatory resolution. FASEB J. 21, 3162–3170 (2007)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [101]
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [101]
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [101]
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [101]
Citations
Cites
A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610 · cited 1×
“Transcript levels and fold change in mRNA were determined as described previously (18).”
MethodSerhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650 · cited 3×
“Studies with anti-inflammatory lipids, the resolvins RvE1 and RvD1, have demonstrated that exposure to PMN attenuates migration across endothelial monolayers (13, 21).”
BackgroundResultSelf-citationSerhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., & Gronert, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.8.1197 · Cited by 1,189
Self-citationArita, M., Bianchini, F., Aliberti, J., Sher, A., Chiang, N., Hong, S., Yang, R., Petasis, N. A., & Serhan, C. N. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042031 · Cited by 922
Self-citationWittamer, V., Franssen, J.-D., Vulcano, M., Mirjolet, J.-F., Le Poul, E., Migeotte, I., Brézillon, S., Tyldesley, R., Blanpain, C., Detheux, M., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030382 · Cited by 888 · cited 2×
“Increasing evidence suggests that the proresolving lipid mediator resolvin E1 (RvE1: 5S,12R,18R-trihydroxyeicosapentaenoic acid), a derivative of omega-3 fatty acid, contributes to resolution of inflammation and has been demonstrated to stimulate the orphan receptor ChemR23 (11, 12 ).”
BackgroundMolecular Circuits of Resolution: Formation and Actions of Resolvins and Protectins
Bannenberg, G. L., Chiang, N., Ariel, A., Arita, M., Tjonahen, E., Gotlinger, K. H., Hong, S., & Serhan, C. N. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.4345 · Cited by 699
Self-citationArita, M., Yoshida, M., Hong, S., Tjonahen, E., Glickman, J. N., Petasis, N. A., Blumberg, R. S., & Serhan, C. N. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409271102 · Cited by 590
Self-citationResolvin D1 and Its Aspirin-triggered 17R Epimer
Sun, Y.-P., Oh, S. F., Uddin, J., Yang, R., Gotlinger, K., Campbell, E., Colgan, S. P., Petasis, N. A., & Serhan, C. N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609212200 · Cited by 537 · cited 1×
“Studies with anti-inflammatory lipids, the resolvins RvE1 and RvD1, have demonstrated that exposure to PMN attenuates migration across endothelial monolayers (13, 21).”
BackgroundSelf-citationRvE1 protects from local inflammation and osteoclastmediated bone destruction in periodontitis
Hasturk, H., Kantarci, A., Ohira, T., Arita, M., Ebrahimi, N., Chiang, N., Petasis, N. A., Levy, B. D., Serhan, C. N., & Van Dyke, T. E. (2006) · The FASEB Journal · doi:10.1096/fj.05-4724fje · Cited by 435 · cited 1×
“RvE1 is generated at sites of inflammation through transcellular metabolism and has been shown to potently inhibit PMN transendothelial migration (13), to attenuate colonic mucosal inflammation in vivo (14, 15), and to resolve oral inflammation in a rabbit periodontitis model (16).”
BackgroundSelf-citationMillán, J., Hewlett, L., Glyn, M., Toomre, D., Clark, P., & Ridley, A. J. (2006) · Nature Cell Biology · doi:10.1038/ncb1356 · Cited by 414 · cited 1×
“CD55 is a well-documented lipid-raft component (31), and ICAM-1 has been demonstrated to be recruited to caveolae (32).”
Background
Cited by
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Serhan, C. N., Chiang, N., & Van Dyke, T. E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2294 · Cited by 2,932
Self-citationTransition from inflammation to proliferation: a critical step during wound healing
Landén, N. X., Li, D., & Ståhle, M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2268-0 · Cited by 1,980
Specialized pro-resolving mediators: endogenous regulators of infection and inflammation
Basil, M. C., & Levy, B. D. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.4 · Cited by 791
The role of neutrophils during intestinal inflammation
Fournier, B. M., & Parkos, C. A. (2012) · Mucosal Immunology · doi:10.1038/mi.2012.24 · Cited by 671
Luissint, A.-C., Parkos, C. A., & Nusrat, A. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.07.008 · Cited by 555
González-Périz, A., Horrillo, R., Ferré, N., Gronert, K., Dong, B., Morán-Salvador, E., Titos, E., Martínez-Clemente, M., López-Parra, M., Arroyo, V., et al. (2009) · The FASEB Journal · doi:10.1096/fj.08-125674 · Cited by 555
“These novel oxygenated products originated from -3PUFAs evoke potent protective actions demonstrable at the nanomolar and picomolar ranges, many of which are related to the resolution of unremitting inflammation (12, 16-20, 36, 46-48).”
BackgroundPeriodontitis: a host‐mediated disruption of microbial homeostasis. Unlearning learned concepts
Bartold, P. M., & Van Dyke, T. E. (2013) · Periodontology 2000 · doi:10.1111/j.1600-0757.2012.00450.x · Cited by 540
“This process leads to the release of cytokines, which stop neutrophil migration to the inflammatory site, attract monocytes that do not release proinflammatory mediators, enhance phagocytosis of bacteria and apoptotic cells by macrophages, direct the movement of phagocytes away from the site via the lymphatics and sti…”
BackgroundSpecialized pro-resolving lipid mediators in the inflammatory response: An update
Bannenberg, G., & Serhan, C. N. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.08.002 · Cited by 464
“The functional importance of the RvE1-CMKLR1 interaction was demonstrated in murine dendritic cells (stimulating down-regulation of IL-12 formation and migration) [87] and in oral epithelial cells where activation of CMKLR1 by RvE1 stimulates transepithelial neutrophil migration [100].”
BackgroundSelf-citationEndogenous pro‐resolving and anti‐inflammatory lipid mediators: a new pharmacologic genus
Serhan, C. N., & Chiang, N. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707489 · Cited by 431
“, 2007) and enhance CD55-dependent clearance of PMN from epithelial surfaces (Campbell et al., 2007).”
BackgroundSelf-citationRheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction
Holers, V. M., Demoruelle, M. K., Kuhn, K. A., Buckner, J. H., Robinson, W. H., Okamoto, Y., Norris, J. M., & Deane, K. D. (2018) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0070-0 · Cited by 417
Haworth, O., Cernadas, M., Yang, R., Serhan, C. N., & Levy, B. D. (2008) · Nature Immunology · doi:10.1038/ni.1627 · Cited by 424
Self-citationNovel Lipid Mediators and Resolution Mechanisms in Acute Inflammation
Serhan, C. N. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100322 · Cited by 421
“mucosal epithelial cells to produce antimicrobial peptides.(43,92) Because LX and Rvs control inflammation by stimulating resolution without immune suppression, limiting local inflammation by reducing PMN, and enhancing the M cleanup, a new chemical mediator function for SPM was introduced to describe their temporal b…”
BackgroundSelf-citationEmerging roles of resolvins in the resolution of inflammation and pain
Ji, R.-R., Xu, Z.-Z., Strichartz, G., & Serhan, C. N. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.08.005 · Cited by 344
Self-citationOld and new generation lipid mediators in acute inflammation and resolution
Stables, M. J., & Gilroy, D. W. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.07.005 · Cited by 334
Acute Lung Injury: How Macrophages Orchestrate Resolution of Inflammation and Tissue Repair
Herold, S., Mayer, K., & Lohmeyer, J. (2011) · Frontiers in Immunology · doi:10.3389/fimmu.2011.00065 · Cited by 328
“It was identified as a natural ligand for the G proteincoupled receptor ChemR23 expressed by epithelial cells (Campbell et al., 2007), dendritic cells (Vermi et al.”
BackgroundAlbanesi, C., Scarponi, C., Pallotta, S., Daniele, R., Bosisio, D., Madonna, S., Fortugno, P., Gonzalvo-Feo, S., Franssen, J.-D., Parmentier, M., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20080129 · Cited by 327
Intestinal alkaline phosphatase: novel functions and protective effects
Lallès, J.-P. (2014) · Nutrition Reviews · doi:10.1111/nure.12082 · Cited by 326
The Dual Role of Neutrophils in Inflammatory Bowel Diseases
Wéra, O., Lancellotti, P., & Oury, C. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5120118 · Cited by 316
“Similar to LXA4, resolvin E1 reduces neutrophil transepithelial migration, and treatment with resolvin E1 reduces damage after TNBS administration [182,183].”
BackgroundResolution of Acute Inflammation in the Lung
Levy, B. D., & Serhan, C. N. (2014) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021113-170408 · Cited by 298
Self-citationResolvins and protectins: mediating solutions to inflammation
Kohli, P., & Levy, B. D. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00290.x · Cited by 292
“, 2000) and facilitating apical PMN clearance from mucosal epithelial cells (Campbell et al., 2007).”
BackgroundEl Kebir, D., Gjorstrup, P., & Filep, J. G. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206641109 · Cited by 289
“It is interesting to note that clearance of apoptotic cells via ChemR23 also occurs at similar low- or subnanomolar RvE1 concentrations (14, 17, 34) as those required to induce neutrophil apoptosis.”
BackgroundDHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation
Duvall, M. G., & Levy, B. D. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.11.001 · Cited by 286
“…Increases CCR5 expression; Regulates Th17 cells Ariel et al 2006; Haworth et al 2008 Neutrophils Inhibits trans-migration and promotes clearance Campbell et al 2007 Macrophages Enhances phagocytosis of apoptotic neutrophils Schwab et al 2007 NK Cells Promotes clearance of eosinophils and…”
BackgroundInfluentialResolvin E1 Receptor Activation Signals Phosphorylation and Phagocytosis
Ohira, T., Arita, M., Omori, K., Recchiuti, A., Van Dyke, T. E., & Serhan, C. N. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.044131 · Cited by 278
Self-citationNovel Anti-Inflammatory-Pro-Resolving Mediators and Their Receptors
N. Serhan, C., Krishnamoorthy, S., Recchiuti, A., & Chiang, N. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026611109060629 · Cited by 276
Self-citationPro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function
Brennan, E., Kantharidis, P., Cooper, M. E., & Godson, C. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00454-y · Cited by 262
Weylandt, K. H., Chiu, C.-Y., Gomolka, B., Waechter, S. F., & Wiedenmann, B. (2012) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2012.01.005 · Cited by 258
The Role of Micronutrients in Support of the Immune Response against Viral Infections
Pecora, F., Persico, F., Argentiero, A., Neglia, C., & Esposito, S. (2020) · Nutrients · doi:10.3390/nu12103198 · Cited by 247
Seki, H., Fukunaga, K., Arita, M., Arai, H., Nakanishi, H., Taguchi, R., Miyasho, T., Takamiya, R., Asano, K., Ishizaka, A., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901809 · Cited by 221
“from apical surfaces in a CD55-dependent manner (45), and RvE1”
BackgroundSelf-citationLima-Garcia, J., Dutra, R., da Silva, K., Motta, E., Campos, M., & Calixto, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01345.x · Cited by 209
“…AT-RvD1 mediators limit the transendothelial migration (Serhan et al., 2002; Sun et al., 2007) and infiltration (Kasuga et al., 2008) of polymorphonuclear (PMN) leukocytes in vivo and regulate leukocyte trafficking as well as clearance of neutrophils from mucosal surfaces (Campbell et al., 2007).”
BackgroundEl‐Sharkawy, H., Aboelsaad, N., Eliwa, M., Darweesh, M., Alshahat, M., Kantarci, A., Hasturk, H., & Van Dyke, T. E. (2010) · Journal of Periodontology · doi:10.1902/jop.2010.090628 · Cited by 203
Campbell, E. L., MacManus, C. F., Kominsky, D. J., Keely, S., Glover, L. E., Bowers, B. E., Scully, M., Bruyninckx, W. J., & Colgan, S. P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914730107 · Cited by 186
“This is an intriguing possibility given that the other known function for RvE1 on mucosal epithelia is to promote the termination and clearance of PMN following transmigration (17), through well-characterized CD55-dependent mechanisms (19, 32).”
BackgroundInfluentialSelf-citationLipid Mediators in Inflammation
Bennett, M., & Gilroy, D. W. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0035-2016 · Cited by 172
“One of the broader immunomodulatory properties of RvE1 is its ability to inhibit neutrophil and dendritic cell accumulation at sites of inflammation by blocking trans-endothelial migration as well as enhancing their clearance from mucosal epithelial cells (110, 285, 287).”
BackgroundZhang, M. J., & Spite, M. (2012) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071811-150726 · Cited by 171
“(d ) Finally, resolvins induce CD55 expression on epithelial cells to block neutrophil transepithelial migration (16).”
BackgroundYoshimura, T., & Oppenheim, J. J. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.10.023 · Cited by 169
SERHAN, C. N. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03396.x · Cited by 166
Self-citationChemerin/chemR23 axis in inflammation onset and resolution
Mariani, F., & Roncucci, L. (2015) · Inflammation Research · doi:10.1007/s00011-014-0792-7 · Cited by 164
Weigert, J., Obermeier, F., Neumeier, M., Wanninger, J., Filarsky, M., Bauer, S., Aslanidis, C., Rogler, G., Ott, C., Schäffler, A., et al. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21091 · Cited by 163
“Exposure of neutrophils to chemerin reduces transepithelial migration, whereas activation of the epithelial ChemR23 stimulates apical clearance of neutrophils, indicating a function of chemerin in the resolution of acute mucosal inflammation.(27) Besides its role in the recruitment of immune cells, chemerin is essenti…”
BackgroundFredman, G., & Serhan, C. N. (2011) · Biochemical Journal · doi:10.1042/bj20110327 · Cited by 158
Self-citationBrazil, J. C., Louis, N. A., & Parkos, C. A. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318281f54e · Cited by 156
“In addition, antibody-mediated blockage of CD55, which also localizes to the luminal surface of the intestinal epithelium, results in the accumulation of PMN at the apical epithelial surface.(39,40) Most recently, a role for the epithelial transmembrane glycoprotein CD44v6 in the detachment of PMN from the apical aspe…”
BackgroundSelf-citationThe Life and Death of Epithelia During Inflammation: Lessons Learned from the Gut
Koch, S., & Nusrat, A. (2012) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-120905 · Cited by 154
Microglia and Monocyte-Derived Macrophages in Stroke
Kim, E., & Cho, S. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0463-1 · Cited by 173
Interplay between intestinal alkaline phosphatase, diet, gut microbes and immunity
Estaki, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i42.15650 · Cited by 146
Inflammatory events in endometrial adenocarcinoma
Wallace, A. E., Gibson, D. A., Saunders, P. T. K., & Jabbour, H. N. (2010) · Journal of Endocrinology · doi:10.1677/joe-10-0072 · Cited by 127
“These perform functions such as promoting the clearance of apoptotic leukocytes, and preventing further chemokine expression by these cells (Campbell et al. 2007).”
BackgroundModulation of Neutrophil Apoptosis and the Resolution of Inflammation through β2 Integrins
El Kebir, D., & Filep, J. G. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00060 · Cited by 121
“Thus, RvE1 inhibits neutrophil recruitment, facilitates efferocytosis (Serhan et al., 2002, 2008; Ohira et al., 2010; Oh et al., 2011; Serhan and Petasis, 2011), promotes mucosal surface clearance (Campbell et al., 2007), and induces generation of LXA4 (Haworth et al., 2008).”
BackgroundSerhan, C. N. (2008) · Journal of Periodontology · doi:10.1902/jop.2008.080231 · Cited by 132
Self-citationKalinec, G. M., Lomberk, G. A., Urrutia, R. A., & Kalinec, F. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00192 · Cited by 124
“In turn, RvD2 and RvE have specific receptors termed, respectively, RvD2-R (Chiang et al., 2015) and RvE-R (Arita et al., 2005; Campbell et al., 2007; Parolini et al., 2007; Cash et al., 2008; Du and Leung, 2009; Barnig et al., 2013).”
BackgroundFrasch, S. C., Berry, K. Z., Fernandez-Boyanapalli, R., Jin, H.-S., Leslie, C., Henson, P. M., Murphy, R. C., & Bratton, D. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807047200 · Cited by 113
Towards targeting resolution pathways of airway inflammation in asthma
Barnig, C., Frossard, N., & Levy, B. D. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.01.004 · Cited by 121
Resolvins: Natural agonists for resolution of pulmonary inflammation
Uddin, M., & Levy, B. D. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.09.002 · Cited by 126
“RvE1 inhibits neutrophil transmigration across endothelial and epithelial barriers to prevent tissue neutrophilia [8,35,80,97], down regulates expression of key neutrophil adhesion molecules (L-selectin, CD11b/CD18) [98], blocks neutrophil oxidative burst [99], stimulates non-phlogistic clearance of apoptotic neutroph…”
BackgroundInfluentialOmega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1
Seki, H., Tani, Y., & Arita, M. (2009) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2009.03.002 · Cited by 131
Self-citationResolvins and protectins: Natural pharmacophores for resolution biology
Levy, B. D. (2010) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2010.02.003 · Cited by 124
“In addition, mechanisms unique to mucosal surfaces exist to release PMNs from the apical surfaces of epithelial cells into the lumen for tissue clearance [18].”
Serhan, C. N. (2008) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2008.09.012 · Cited by 108
“They also stimulate the uptake of apoptotic PMNs [9] and activate endogenous anti-microbial defense mechanisms [10] as well as clearance on mucosal surfaces [11].”
BackgroundSelf-citationNorling, L. V., & Serhan, C. N. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02235.x · Cited by 115
Self-citationWeissmüller, T., Campbell, E. L., Rosenberger, P., Scully, M. M., Beck, P. L., Furuta, G. T., & Colgan, S. P. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35874 · Cited by 96
Self-citationResolvin E1 is a pro-repair molecule that promotes intestinal epithelial wound healing
Quirós, M., Feier, D., Birkl, D., Agarwal, R., Zhou, D. W., Garcı́a, A. J., Parkos, C. A., & Nusrat, A. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1921335117 · Cited by 100
Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer
Janakiram, N. B., Mohammed, A., & Rao, C. V. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9311-2 · Cited by 96
Neutrophil Resolvin E1 Receptor Expression and Function in Type 2 Diabetes
Freire, M., Dalli, J., Serhan, C. N., & Dyke, T. E. V. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1601543 · Cited by 98
Self-citationGhanem, E. N. B., Clark, S. A., Du, X., Wu, D., Camilli, A., Leong, J. M., & Meydani, S. N. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1402401 · Cited by 99
“Production of the antiadhesive molecule CD55, sometimes coupled with downregulation of ICAM-1 (50), can facilitate release of PMNs from the epithelial surface as the final step in transmigration (30).”
BackgroundInfluentialSpecialized Proresolving Mediators in Innate and Adaptive Immune Responses in Airway Diseases
Krishnamoorthy, N., Abdulnour, R.-E. E., Walker, K. H., Engstrom, B. D., & Levy, B. D. (2018) · Physiological Reviews · doi:10.1152/physrev.00026.2017 · Cited by 89
EPA- and DHA-derived resolvins' actions in inflammatory bowel disease
Schwanke, R. C., Marcon, R., Bento, A. F., & Calixto, J. Β. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.08.050 · Cited by 89
“…migration associated with a reduction in the release of proinflammatory cytokines and an increase in phagocytic activity of macrophages, which in turn cause tissue “cleaning” (Bannenberg et al., 2005; Campbell et al., 2007; Isobe et al., 2012; Ogawa et al., 2009; Seki et al., 2009).”
BackgroundAugé, C., Chêne, G., Dubourdeau, M., Desoubzdanne, D., Corman, B., Palea, S., Lluel, P., Vergnolle, N., & Coelho, A.-M. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.03.008 · Cited by 93
“Considering the demonstrated protective effects of lipoxins and resolvins on mucosal architecture (Campbell et al., 2007; Fierro et al., 2003; Fiorucci et al., 2003), those metabolites released upon aspirin treatment might also play a role in the preservation of epithelial structures observed in cystitic rats treated…”
BackgroundUno, H., Furukawa, K., Suzuki, D., Shimizu, H., Ohtsuka, M., Kato, A., Yoshitomi, H., & Miyazaki, M. (2016) · Surgery · doi:10.1016/j.surg.2016.01.019 · Cited by 74
Eicosanoid pathway in colorectal cancer: Recent updates
Tunçer, S., & Banerjee, S. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i41.11748 · Cited by 78
Lipid Mediator Profiling in Pulmonary Disease
Lundström, S. L., Balgoma, D., Wheelock, Å. M., Haeggström, J. Z., Dahlén, S., & Wheelock, C. E. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111795909087 · Cited by 71
“For example, RvE1 decreases polymorphonuclear leukocytes (PMNs) tissue accumulation by blocking human PMN transendothelial migration [267] and facilitates apical PMN clearance from mucosal epithelial cells [270], binds to the LTB4 receptor BLT1 as a partial agonist and consequently attenuates proinflammatory signaling…”
BackgroundTherapeutic potential of pro-resolving mediators in diabetic kidney disease
Vartak, T., Godson, C., & Brennan, E. P. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113965 · Cited by 72
Weylandt, K. H., Nadolny, A., Kahlke, L., Köhnke, T., Schmöcker, C., Wang, J., Lauwers, G. Y., Glickman, J. N., & Kang, J. X. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.08.011 · Cited by 79
“Particularly the EPA and DHA derived resolvins have been implicated in the processes involved in inflammation resolution [23, 42].”
Resolution of Adipose Tissue Inflammation
González‐Périz, A., & Clària, J. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.77 · Cited by 78
Darwesh, A. M., Bassiouni, W., Sosnowski, D. K., & Seubert, J. M. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107703 · Cited by 75
“This includes preventing the migration of neutrophils and monocytes across epithelial cells and promoting clearance of polymorphonuclear (PMNs) leukocytes, apoptotic cells and debris from the site of inflammation (Campbell et al., 2007; Serhan et al., 2002).”
Maciuszek, M., Cacace, A., Brennan, E. P., Godson, C., & Chapman, T. M. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113167 · Cited by 63
Resolvin D1 protects periodontal ligament
Mustafa, M., Zarrough, A., Bolstad, A. I., Lygre, H., Mustafa, K., Hasturk, H., Serhan, C., Kantarci, A., & Van Dyke, T. E. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00242.2012 · Cited by 63
“Collectively, lipoxins function to resolve the acute inflammatory response with minimal damage to the surrounding tissue (5, 47).”
BackgroundSelf-citationControl of Neutrophil Inflammation at Mucosal Surfaces by Secreted Epithelial Products
Szabady, R. L., & McCormick, B. A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00220 · Cited by 71
Maskrey, B. H., Megson, I. L., Rossi, A. G., & Whitfield, P. D. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200723 · Cited by 69
Kotlyarov, S. N., & Котлярова, А. А. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312803 · Cited by 64
Hsiao, H.-M., Thatcher, T. H., Levy, E. P., Fulton, R. A., Owens, K. M., Phipps, R. P., & Sime, P. J. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400313 · Cited by 60
Napimoga, M. H., Trindade‐da‐Silva, C. A., Carregaro, V., Farnesi-de-Assunção, T. S., Duarte, P. M., de Melo, N. F. S., & Fraceto, L. F. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200730 · Cited by 59
“across the epithelial cell surface, promoting active inflammatory resolution (41).”
BackgroundDuvall, M. G., Brüggemann, T. R., & Levy, B. D. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.04.003 · Cited by 59
“Like LXA4, RvD1 (Eickmeier et al., 2013; Wang et al., 2011), RvE1 (Campbell et al., 2007; Seki et al., 2010), and MaR1 (Krishnamoorthy et al., 2015) can also inhibit trans-epithelial migration of neutrophils in murine models of lung infection and injury.”
InfluentialRoles of resolvins in the resolution of acute inflammation
Qu, Q., Xuan, W., & Fan, G.-H. (2014) · Cell Biology International · doi:10.1002/cbin.10345 · Cited by 65
Antimicrobial Aspects of Inflammatory Resolution in the Mucosa: A Role for Proresolving Mediators
Campbell, E. L., Serhan, C. N., & Colgan, S. P. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100150 · Cited by 58
“For example, RvE1 reduces ocular herpes simplex-induced inflammation (15); protectin D1 reduces ocular epithelial injury (16); resolvin D1 (RvD1), RvE1, and protectin D1 each reduce airway inflammation (17–20); and RvE1 reduces oral inflammation of the periodontium (21) and stimulates the clearance of apoptotic cell f…”
BackgroundSelf-citationResolvin D1 Reduces the Immunoinflammatory Response of the Rat Eye following Uveitis
Settimio, R., Clara, D. F., Franca, F., Francesca, S., & Michele, D. (2012) · Mediators of Inflammation · doi:10.1155/2012/318621 · Cited by 56
“Bolus of resolvin D1 (RvD1; 10–100–1000 ng/kg in 200 μL of sterile saline via the tail vein) significantly and dose-dependently (i) reduced the development of the ocular derangement caused by LPS; (ii) reduced the clinical score attributed to EIU; (iii) reduced the protein concentration and…”
Korkmaz, B., Lesner, A., Letast, S., Mahdi, Y. K., Jourdan, M., Dallet‐Choisy, S., Marchand-Adam, S., Kellenberger, C., Viaud‐Massuard, M., Jenne, D. E., et al. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0362-z · Cited by 56
Resolution of Inflammation in Asthma
Levy, B. D., Vachier, I., & Serhan, C. N. (2012) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2012.06.006 · Cited by 63
“To this end, proresolving mediators decrease allergic edema,(27) recruit monocytes in a nonphlogistic fashion,(28) increase phagocytosis and efferocytosis by macrophages,(29) increase chemokine scavenging by apoptotic neutrophils (via C-C chemokine receptor type 5 [CCR5] expression),(30) enhance luminal clearance of t…”
Self-citationVassiliou, E. K., Kesler, O. M., Tadros, J. H., & Ganea, D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4534 · Cited by 56
“In addition, RvE1 stimulates neutrophil clearance through a CD55-dependent mechanism (18).”
BackgroundBiological Roles of Resolvins and Related Substances in the Resolution of Pain
Lim, J. Y., Park, C., & Hwang, S. W. (2015) · BioMed Research International · doi:10.1155/2015/830930 · Cited by 61
“This protein ligand has been shown to exhibit immunological effects similar to those of RvE1 in both in vivo and in vitro experimental models [48–52].”
ResultInnate immunity is a key factor for the resolution of inflammation in asthma
Barnig, C., & Levy, B. D. (2015) · European Respiratory Review · doi:10.1183/09059180.00012514 · Cited by 59
The Inflammatory Tissue Microenvironment in IBD
Colgan, S. P., Curtis, V. F., & Campbell, E. L. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e31828dcaaf · Cited by 57
Self-citationDietary modulation of the inflammatory cascade
Dawson, D. R., Branch‐Mays, G. L., González, O. A., & Ebersole, J. L. (2013) · Periodontology 2000 · doi:10.1111/j.1600-0757.2012.00458.x · Cited by 61
Darwesh, A. M., Sosnowski, D. K., Lee, T. Y., Keshavarz-Bahaghighat, H., & Seubert, J. M. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.04.037 · Cited by 56
“neutrophils and monocytes across epithelial cells and promoting clearance of PMNs, apoptotic cells, and debris from the site of inflammation [356, 363].”
BackgroundBörgeson, E., & Godson, C. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00318 · Cited by 51
“Macrophages Stimulates efferocytosis while reducing IFN-γ and IL-6 (Schwab et al., 2007) PMN Decreases transendothelial and epithelial migration (Campbell et al., 2007) Stimulates L-selectin shedding, while reducing CD18 expression and inhibiting PMN rolling in vivo (Dona et al., 2008) Attenuates…”
BackgroundEl-Wakeel, N., & Hazzaa, H. H. A. (2015) · Journal of Periodontal Research · doi:10.1111/jre.12257 · Cited by 57
“These compounds have potent anti-inflammatory and immune-regulatory effects by inhibiting superoxide production, chemotaxis and migration of PMNs and directly or indirectly reduce the production of proinflammatory enzymes and cytokines (14,16, 33,34).”
BackgroundLiu, G., Gong, Y., Zhang, R., Piao, L., Li, X., Liu, Q., Yan, S., Shen, Y., Guo, S., Zhu, M., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201800173r · Cited by 48
“Transwellassayswereperformedas previouslydescribed (38).”
Resolvins as Regulators of the Immune System
Seki, H., Sasaki, T., Ueda, T., & Arita, M. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.72 · Cited by 53
“RvE1 potently attenuated f-MET-Leu-Phe (fMLP)–induced PMN transmigration across KB oral epithelial cells in a concentration-dependent manner[22].”
BackgroundSelf-citationLevy, B. D., Zhang, Q. Y., Bonnans, C., Primo, V., Reilly, J. J., Perkins, D. L., Liang, Y., Arnaout, M. A., Nikolic, B., & Serhan, C. N. (2010) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2010.09.002 · Cited by 50
Self-citationNagatake, T., & Kunisawa, J. (2019) · International Immunology · doi:10.1093/intimm/dxy086 · Cited by 46
Neonatal necrotizing enterocolitis
Maheshwari, A., Corbin, & Schelonka, R. L. (2011) · Research and Reports in Neonatology · doi:10.2147/rrn.s23459 · Cited by 54
Parisi, G. F., Carota, G., Castruccio Castracani, C., Spampinato, M., Manti, S., Papale, M., Di Rosa, M., Barbagallo, I., & Leonardi, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052465 · Cited by 43
Resolution of inflammation in oral diseases
Eltay, E. G., & Dyke, T. E. V. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108453 · Cited by 46
Halade, G. V., Black, L. M., & Verma, M. K. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.02.014 · Cited by 47
Function of Pro-Resolving Lipid Mediator Resolvin E1 in Type 2 Diabetes
Sima, C., Paster, B. J., & Dyke, T. E. V. (2018) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2018026750 · Cited by 45
Saving Problematic Mucosae: SPMs in Intestinal Mucosal Inflammation and Repair
Quirós, M., & Nusrat, A. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.12.004 · Cited by 47
Mcl-1 is vital for neutrophil survival
Murphy, M. P., & Caraher, E. M. (2015) · Immunologic Research · doi:10.1007/s12026-015-8655-z · Cited by 42
Metadata
- Authors
- Campbell, E. L., Louis, N. A., Tomassetti, S. E., Canny, G. O., Arita, M., Serhan, C. N., & Colgan, S. P.
- Affiliations
- Brigham and Women's Hospital (US)
- University of Colorado Denver (US)
- ORCID
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2007-05-11
- Volume
- 21
- Issue
- 12
- Pages
- 3162-3170
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2121204231
- Cited by
- 205
- References
- 39
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 8 · 2023: 8 · 2022: 11 · 2021: 12 · 2020: 8 · 2019: 7 · 2018: 12 · 2017: 6 · 2016: 11 · 2015: 14 · 2014: 8 · 2013: 22 · 2012: 11
- FWCI
- 14.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- National Institutes of Health (DK-50189, HL-60569, DE-13499)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- resolvin E1, inflammation resolution, neutrophil clearance, mucosal epithelium, transepithelial migration, chemerin, ChemR23, CD55, two-hit model, eicosanoid signaling
- MeSH terms
- Animals, Cell Line, Cell Movement, Epithelial Cells, Humans, Inflammation, Mucous Membrane, Neutrophils, Promoter Regions, Genetic, Eicosapentaenoic Acid, Intercellular Adhesion Molecule-1, Chemokines, CD55 Antigens, Intercellular Signaling Peptides and Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.